作为多发性硬化症攻击的表现,超性乳清血
Sahand Golparvar1, Saba Naghavi1,2, Iman Adibi1,2
1Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.
BMJ neurology open
|October 16, 2025
概括
多发性硬化症 (MS) 可能会导致高血,导致银河. 在这种情况下,用甲基前尼索隆治疗多发性硬化症使益生菌水平正常化,并且在没有特定的超益生菌血症药物的情况下消除了症状.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
背景情况:
- 多发性硬化症 (MS) 是一种慢性炎症神经系统疾病.
- 超益生菌性血症 (Hyperprolactinemia) 是由益生菌水平升高的特征,影响6.7%的多发性硬化症患者.
- 银河是多发性硬化症患者的罕见症状.
研究的目的:
- 报告一个患有多发性硬化症的病例,呈现出高血和银河.
- 为了调查MS和高血糖性乳腺炎之间的潜在关联.
- 为了评估在MS管理的背景下,高血性乳腺炎的治疗反应.
主要方法:
- 案例报告的方法.
- 一位31岁多发性硬化症女性患者的临床观察.
- 血清前素水平的监测和垂体腺成像.
主要成果:
- 患者表现出银河和血清前素水平升高, pituitary 腺正常.
- 静脉注射甲基普雷迪尼索隆治疗MS导致益生菌水平正常化.
- 在没有使用多巴胺激素剂的情况下,甲基前尼索隆 (methylprednisolone) 给药后,银河症得到缓解.
结论:
- 这一案例表明多发性硬化症和高血性乳腺炎之间存在潜在的联系.
- 当高血与MS相关时,针对MS的治疗可能就足够了.
- 如果MS是底层原因,则可能不需要针对高血的特殊治疗.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Mania and Antimanic Drugs: Overview
545
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
545
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K


